Biallelic gene inactivation of NF2 resulting from chr22 monosomy and concurrent mutations in the remaining NF2 allele are characteristic alterations in multiple central and peripheral nervous system tumors in addition to meningioma including schwannomas and ependymomas (6). This evidence concerns the gene NF2 and ependymoma.